Products & Services

See also: Categories | Featured Products | Technical Articles | More Information
Page: 1 2 Next

Conduct Research Top

  • Medical Device Link .
    complex polyethylene glycols, polyvinyl acids, and microparticles of numerous sorts are produced in such large batches that a single lot of one of these polymers can be used for several years� worth of IVDs. Previous editions of the IVD Technology Buyers Guide have described and categorized
  • Medical Device Link .
    complex polyethylene glycols, polyvinyl acids, and microparticles of numerous sorts are produced in such large batches that a single lot of one of these polymers can be used for several years' worth of IVDs. Buyers Guide have described and categorized the varieties of chemical and biochemical reagents
  • A Wave, Suspended: Follow-on Biologics
    procedures established for small molecules, human growth hormone, insulin, interleukins and interferons are available, as are versions of therapeutic proteins modified with polyethylene glycol (PEG) residues to improve pharmacokinetics.
  • New wound-healing materials on the horizon
    III to a synthetic material called polyethylene glycol. Mixing solutions of this peptide-polyethylene glycol combination with heparin instantly produces a three-dimensional matrix. "It's a very rapid assembly and the matrix can take any shape, " says Panitch, who specializes in regenerative medicine
  • Medical Device Link . FACTORS IN SELECTING MEDICAL SILICONES
    is a four-part evaluation involving animal (mouse and rabbit) testing of extracts of saline, vegetable oil, alcohol, and polyethylene glycol along with a 5-day rabbit intramuscular implantation test. While this level of testing is widely used and accepted in the medical products business, the significance of the
  • Drug Delivery: The "Great Equalizer "
    ,? Haley observes. Perhaps the most prominent, technologically compelling example is PEGylation of proteins and peptides as practiced by Nektar Therapeutics (San Carlos, Calif.). Through PEGylation, polyethylene glycol residues are chemically attached to peptides and proteins to improve
  • Controlled Release Moves Beyond Patent Extension
    . Mechanical prolongation of drug release, although thus far dominating CR markets, is not the only strategy. Conjugation with polyethylene glycol (PEG; PEGylation ) has created immense value for developers of protein drugs. When attached to proteins or peptides, highly water-soluble PEG polymer
  • A Wave, Suspended: Follow-on Biologics
    procedures established for small molecules, human growth hormone, insulin, interleukins and interferons are available, as are versions of therapeutic proteins modified with polyethylene glycol (PEG) residues to improve pharmacokinetics. Part of the challenge that FDA faces is the sheer complexity

More Information Top

Lock Indicates content that may require registration and/or purchase. Powered by IHS Goldfire